Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rocket Pharmaceuticals (RCKT) Other Operating Expenses (2017 - 2025)

Rocket Pharmaceuticals (RCKT) has disclosed Other Operating Expenses for 4 consecutive years, with $271000.0 as the latest value for Q2 2025.

  • Quarterly Other Operating Expenses changed N/A to $271000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $271000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at -$78.2 million for FY2018, 118.81% down from the prior year.
  • Other Operating Expenses hit $271000.0 in Q2 2025 for Rocket Pharmaceuticals, up from -$1000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $271000.0 in Q2 2025 to a low of $271000.0 in Q2 2025.